Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?
Saint-Laurent C, Mazeyrie L, Tajan M, Paccoud R, Castan-Laurell I, Valet P, Edouard T, Pradère JP, Dray C, Yart A. Saint-Laurent C, et al. Among authors: castan laurell i. Biomedicines. 2022 Aug 31;10(9):2139. doi: 10.3390/biomedicines10092139. Biomedicines. 2022. PMID: 36140242 Free PMC article. Review.
Apelin, a promising target for type 2 diabetes treatment?
Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Castan-Laurell I, et al. Trends Endocrinol Metab. 2012 May;23(5):234-41. doi: 10.1016/j.tem.2012.02.005. Epub 2012 Mar 22. Trends Endocrinol Metab. 2012. PMID: 22445464 Review.
Apelin and energy metabolism.
Bertrand C, Valet P, Castan-Laurell I. Bertrand C, et al. Among authors: castan laurell i. Front Physiol. 2015 Apr 10;6:115. doi: 10.3389/fphys.2015.00115. eCollection 2015. Front Physiol. 2015. PMID: 25914650 Free PMC article. Review.
[The APJ receptor: a new therapeutic approach in diabetic treatment].
Masri B, Dray C, Knauf C, Valet P, Castan-Laurell I. Masri B, et al. Among authors: castan laurell i. Med Sci (Paris). 2015 Mar;31(3):275-81. doi: 10.1051/medsci/20153103013. Epub 2015 Apr 8. Med Sci (Paris). 2015. PMID: 25855281 Free article. Review. French.
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor.
Personnaz J, Piccolo E, Dortignac A, Iacovoni JS, Mariette J, Rocher V, Polizzi A, Batut A, Deleruyelle S, Bourdens L, Delos O, Combes-Soia L, Paccoud R, Moreau E, Martins F, Clouaire T, Benhamed F, Montagner A, Wahli W, Schwabe RF, Yart A, Castan-Laurell I, Bertrand-Michel J, Burlet-Schiltz O, Postic C, Denechaud PD, Moro C, Legube G, Lee CH, Guillou H, Valet P, Dray C, Pradère JP. Personnaz J, et al. Among authors: castan laurell i. Sci Adv. 2022 Mar 25;8(12):eabg9055. doi: 10.1126/sciadv.abg9055. Epub 2022 Mar 25. Sci Adv. 2022. PMID: 35333579 Free PMC article.
38 results